<i>SF3B1</i> Mutations in Hematological Malignancies
Recently, mutations in the genes involved in the spliceosome have attracted considerable interest in different neoplasms. Among these, <i>SF3B1</i> mutations have acquired great interest, especially in myelodysplastic syndromes, as they identify a subgroup of patients who can benefit fro...
Main Authors: | Daniela Cilloni, Federico Itri, Valentina Bonuomo, Jessica Petiti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/19/4927 |
Similar Items
-
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process
by: Moqin Jiang, et al.
Published: (2023-03-01) -
Phylogenetic Analysis of Spliceosome SF3a2 in Different Plant Species
by: Yuan Tian, et al.
Published: (2023-03-01) -
Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer
by: Claudio Sette, et al.
Published: (2022-04-01) -
The metabolic reprogramming and vulnerability of SF3B1 mutations
by: W. Brian Dalton
Published: (2020-05-01) -
<i>TP53</i> Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
by: Heba Alkhatabi, et al.
Published: (2022-03-01)